Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to $882207.0.

  • Pharma-Bio Serv's Operating Expenses rose 17.11% to $882207.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $3.5 million, marking a year-over-year decrease of 672.86%. This contributed to the annual value of $3.5 million for FY2025, which is 672.86% down from last year.
  • As of Q4 2025, Pharma-Bio Serv's Operating Expenses stood at $882207.0, which was up 17.11% from $888139.0 recorded in Q3 2025.
  • Pharma-Bio Serv's Operating Expenses' 5-year high stood at $6.3 million during Q4 2021, with a 5-year trough of $860300.0 in Q1 2025.
  • Over the past 5 years, Pharma-Bio Serv's median Operating Expenses value was $937479.5 (recorded in 2022), while the average stood at $1.2 million.
  • In the last 5 years, Pharma-Bio Serv's Operating Expenses soared by 42214.09% in 2021 and then crashed by 8507.73% in 2022.
  • Over the past 5 years, Pharma-Bio Serv's Operating Expenses (Quarter) stood at $6.3 million in 2021, then plummeted by 85.08% to $939683.0 in 2022, then increased by 4.46% to $981570.0 in 2023, then decreased by 10.28% to $880700.0 in 2024, then increased by 0.17% to $882207.0 in 2025.
  • Its last three reported values are $882207.0 in Q4 2025, $888139.0 for Q3 2025, and $917048.0 during Q2 2025.